Hookipa Pharma Inc stock recorded solid gain of 5.04% during the past week , while HOOK stock went down by -11.35 %, Hookipa Pharma Inc stock trades only 12.6% above its 52 week low.
Hookipa Pharma Inc 's share price is delayed for 15 minutes
Select the Period on the chart to see the HOOK.NASDAQ's share price performance, or type custom period of your choice
In a recent press release dated January 7, 2025, HOOKIPA Pharma Inc. (NASDAQ: HOOK) informed shareholders about important updates regarding U.K. disclosure requirements. As a clinical-stage biopharmaceutical company specializing in next-generation immunotherapeutics, HOOKIPA is currently focused on innovative treatments for cancer and serious infectious diseases. Key Facts from the Press Release1. Company Overview: HOOKIPA Pharma is involved in the development of cutting-edge immunotherapeutics, indicating a focus on expanding the frontiers of cancer treatment and addressing critical infectious diseases.2. U.K. Disclosure Notice: The company s announcement specifically addressed compliance with U.K. disclosure requirements, an aspect often crucial for companies operating in or having stakeholders in the European market. This implies HOOKIPA?s commitment to transparency and regulatory adherence, which reassures investors and potential stakeholders.
Hookipa Pharma Implements Reverse Stock Split to Improve Share Value On July 9, 2024, HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA) will undergo a 1-for-10 reverse stock split of its outstanding shares of common stock, as announced in a recent press release. This strategic decision aims to enhance the company s share value and boost investor confidence. HOOKIPA Pharma is a pioneering biopharmaceutical company that focuses on developing a breakthrough class of immunotherapeutics using its innovative arenavirus platform. By leveraging the unique properties of arenaviruses, HOOKIPA aims to transform the treatment landscape for various diseases, including infectious diseases and cancers.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
